XTalks

JANUARY 24, 2024

In this episode, Ayesha talked about some of the trends in the life sciences to watch out for in 2024. Read the full article here: Life Science Trends to Look Out for in 2024 The weekly podcast is available for streaming every Wednesday on Spotify , Apple Music and wherever you stream your podcasts.

Life Science 52

Life Science Clinical Research Drugs Development 52

Drug Discovery World

APRIL 17, 2024

Bios Health Group has launched the Bios Innovation Circle – a new venture studio and strategic hub, designed to support biotechnology and life science companies towards growing success. A real revolution in life science development.”

Life Science 52

Life Science Clinical Research Marketing Development 52

XTalks

FEBRUARY 14, 2023

The life science industry is constantly evolving, making it difficult to stay ahead of the curve. There’s no doubt that pharmaceutical and biotechnology organizations are utilizing innovative technology solutions across all sectors of drug development, research and development, supply chain, manufacturing and more.

Life Science 98

Life Science Clinical Trials Clinical Trials Development 98

Pharmaceutical Technology

JULY 28, 2022

In the life sciences sector, one country is significantly outstripping others for FDI. Data shows that almost 40% of all life sciences subsidiaries are located in the US. After all, around a third of the world’s leading life sciences corporations have their headquarters in the country. Industry clusters.

Life Science 130

Life Science Marketing Production Research 130

XTalks

APRIL 3, 2024

This episode features an interview with Bruce Culleton, MD, CEO, ProKidney , a late clinical-stage biotech company focused on the development of a pioneering cell therapy candidate that aims to transform the treatment landscape for chronic kidney disease. The candidate is currently being evaluated in Phase II and Phase III clinical trials.

Life Science 105

Life Science Clinical Trials Clinical Trials Manufacturing 105

XTalks

FEBRUARY 14, 2024

This episode features an interview with Yang Liu, PhD, founder, chairman, CEO and chief scientific officer; and Abid Ansari, MBA, Chief Financial Officer at OncoC4 , a clinical-stage biopharmaceutical company focused on developing novel treatments for cancer. Subscribe to the Xtalks Life Science Podcast to never miss a new episode.

Life Science 119

Life Science DNA Production Clinical Trials 119

XTalks

JULY 19, 2022

The life science industry is dynamic and progressive with 2022 exemplifying significant growth. Agile life science companies that were able to adapt to the challenges of the pandemic and ongoing global regulations prospered since the last two years.

Life Science 98

Life Science Regulation Vaccination Vaccine 98

Drug Discovery World

MARCH 15, 2024

Valneva Scotland scooped two prizes at Scotland’s Life Sciences Awards 2024, including the award for Innovation – Pharma Services And Drug Discovery, in a ceremony on 14 March in Glasgow. Valneva also received the Outstanding Skills Development Award.

Life Science 59

Life Science Vaccination Vaccine Clinical Trials 59

XTalks

AUGUST 23, 2023

This episode features an interview with Dr. William Williams, CEO of BriaCell Therapeutics, a biotech company based in Philadelphia that is dedicated to developing novel immunotherapies to fight cancer and improve patient lives. Subscribe to the Xtalks Life Science Podcast to never miss a new episode.

Life Science 98

Life Science Clinical Trials Clinical Trials FDA Approval 98

AuroBlog - Aurous Healthcare Clinical Trials blog

JANUARY 9, 2024

Experts in the life-sciences industry are of the view that doing away with human studies for new drugs in India is unscientific and risky as patients here have different anthropometry.

Trials 134

Trials Life Science Clinical Trials Clinical Trials 134

XTalks

JUNE 14, 2023

The FNIH recently announced that the AMP Bespoke Gene Therapy Consortium has selected eight rare diseases for its clinical trial portfolio. Xtalks spoke with Dr. Silverthorm about the consortium’s new rare disease clinical trial portfolio. Subscribe to the Xtalks Life Science Podcast to never miss a new episode.

Gene Therapy 98

Gene Therapy Life Science Gene Clinical Trials 98

XTalks

MARCH 27, 2024

He is responsible for evidence portfolio across two therapeutic indications, chronic kidney disease and heart failure, encompassing seven active trials and studies and more than 3,000 US patients. Dr. Perkins has also led the development and implementation of innovative digital educational outreach campaigns for primary care physicians.

Life Science 105

Life Science Development Trials 105

pharmaphorum

DECEMBER 8, 2022

Life Sciences Council. Do you know about the Life Sciences Council (LSC)? The LSC has a website on Gov.uk, but the page says Life Sciences Council. A post from the director of health and life sciences at Innovate UK, Richard J Hebdon, also bigged up the news before the Council met about four health missions.

Life Science 105

Life Science Medicine Branding Research 105

Drug Discovery World

MARCH 7, 2023

For International Women’s Day, DDW’s Diana Spencer celebrates some of the women in leadership making an impact on the drug discovery and life sciences sector. The life sciences sector has traditionally outperformed others when it comes to attracting women to its workforce. Anti-ageing science therefore has huge value.

Life Science 98

Life Science DNA Clinical Development Development 98

XTalks

JANUARY 20, 2022

Life science consulting can be a rewarding career and the job outlook is promising for the future. . Perhaps you have heard of life science consulting jobs but do not exactly know what type of work is involved, or the education and experience needed to become a life science consultant. Job Description.

Life Science 98

Life Science Production Marketing Big Data 98

XTalks

DECEMBER 20, 2023

In 2023, there were significant advancements and notable trends in the life sciences. These advancements and trends addressed important industry challenges and offered opportunities to foster innovations and solutions in areas including drug development, healthcare and medical devices. billion in 2022.

Life Science 59

Life Science Clinical Trials Clinical Trials FDA Approval 59

Pharmaceutical Technology

APRIL 14, 2023

Clinical-stage biopharmaceutical company TORL BioTherapeutics has raised $158m in a Series B financing round for advancing the development of new biologics for cancer treatment. TORL BioTherapeutics is a newly formed, US-based company focused on the development of novel antibody-based therapeutics for cancer patients. CLDN 18.2).

Development 264

Development Clinical Trials Clinical Trials Life Science 264

Drug Discovery World

JULY 11, 2022

Biotechnology company Awakn Life Sciences has received funding from Innovate UK to help it advance its ketamine-assisted therapy programme to market in the UK and US. . Awakn Life Sciences has developed a ketamine-assisted therapy programme for treating alcohol use disorder (AUD). Official comments .

Life Science 98

Life Science Clinical Trials Clinical Trials Trials 98

Pharmaceutical Technology

FEBRUARY 15, 2023

JSR Life Sciences’ business unit Similis Bio is planning to collaborate with Novel351k for the development of three biosimilar programmes targeting cancer and autoimmune diseases. Under the terms of the initial deal, Similis Bio will handle the development of cell lines, analytics, process development, and cGMP production.

Development 147

Development Life Science Manufacturing Clinical Trials 147

Pharmaceutical Technology

APRIL 10, 2023

Aviceda Therapeutics (Aviceda) has entered into a strategic partnership with the Patrick G Johnston Centre for Cancer Research at Queen’s University Belfast (QUB) for the development of next-generation glyco-immune therapeutics. Aviceda Glycotech has been created as an oncology-focused spin-off company from Aviceda Therapeutics and Queen’s.

Development 259

Development Life Science Clinical Trials Clinical Trials 259

Drug Discovery World

MAY 16, 2024

million development in Manchester intended to enhance the city’s Oxford Road Corridor knowledge quarter as a hub for life sciences and technology innovation. Greenheys at Manchester Science Park is scheduled for completion in Summer 2026 and will span 131,000 sq ft across six floors. Work has started on a £60 ($75.1)

Biobanking 59

Biobanking Development Life Science Genome 59

XTalks

NOVEMBER 15, 2023

Lahar Mehta, Head of Global Clinical Development at Amylyx Pharmaceuticals, who spoke to Xtalks about Amylyx’s clinical trial design of ORION, a Phase III Global Study of AMX0035 (Relyvrio) in Progressive Supranuclear Palsy (PSP). Hear from Dr. Mehta about the details of the trial, which is set to begin in December this year.

Life Science 52

Life Science Trials Clinical Trials Clinical Trials 52

XTalks

MAY 15, 2024

Ovid Therapeutics is a biopharmaceutical company focused on the development of medicines for epilepsies and seizure-related neurological disorders. Subscribe to the Xtalks Life Science Podcast to never miss a new episode. Phil, MB BChir, CEO and Chairman of Ovid Therapeutics Inc. ,

Life Science 69

Life Science Medicine Clinical Research Development 69

Pharmaceutical Technology

SEPTEMBER 23, 2022

RA Capital Management led the financing round, which also saw participation from Bain Capital Life Sciences and BB Biotech. In the trial, HU6 treatment also led to a substantial decline in liver, visceral and total body fat while preserving skeletal muscle mass.

Clinical Development 242

Clinical Development Development Life Science Trials 242

Pharmaceutical Technology

OCTOBER 6, 2022

BioLink Life Sciences has received a contract worth $750,000 from the US Biomedical Advanced Research and Development Authority (BARDA) to develop Ramatroban for treating Covid-19 pneumonia patients in the hospital setting. The trial will also lay the ground for additional trials for acute and long Covid in the US.

Development 162

Development Life Science Immune Response Trials 162

XTalks

MAY 1, 2024

In this episode, Ayesha spoke with Robert Barrow, CEO and Board Director at MindMed , a clinical-stage biopharmaceutical company developing novel product candidates to treat brain health disorders. After joining MindMed as Chief Development Officer in January 2021, he was named CEO in June 2021.

Life Science 52

Life Science Production Development Drugs 52

Bio Pharma Dive

MARCH 30, 2021

Two drugs developed by Wave Life Sciences didn't appear to have an effect on disease-causing proteins, another setback for Huntington's research after disappointing results last week from Roche and Ionis.

Life Science 300

Life Science Drugs Trials Protein 300

XTalks

APRIL 14, 2021

In this episode of the Xtalks Life Science Podcast, Sarah revisits two Parkinson’s biotech companies — Prevail Therapeutics and Voyager Therapeutics — to see what progress they’ve made in their gene therapy clinical development programs since April 2019. Parkinson’s and Melanoma Share an Amyloid Link, Says New Research.

Life Science 98

Life Science Gene Therapy Development Drugs 98

Outsourcing Pharma

APRIL 15, 2024

Michael Fronstin, global head of client partnership and commercialization at the company said the combination of Oracleâs life sciences expertise and platform technology help CROs win more business and run trials more efficiently.

Life Science 87

Life Science Trials Clinical Development Development 87

XTalks

DECEMBER 29, 2022

The life sciences and healthcare are among the biggest industries globally, and their significance was particularly highlighted during the past couple of years by the COVID-19 pandemic. Given the hyperfocus on the life sciences thanks to COVID, consumers appear to be more autonomous and vocal about their medical demands and choices.

Life Science 52

Life Science Gene Therapy Gene Manufacturing 52

XTalks

FEBRUARY 28, 2024

Ayesha spoke about how the Rare Disease Day campaign helps increase awareness about rare diseases, promotes research and development, supports advocacy for policies supporting patients and their families and brings together a global rare disease community. Subscribe to the Xtalks Life Science Podcast to never miss a new episode.

Life Science 52

Life Science Research Genetics Drugs 52

pharmaphorum

OCTOBER 28, 2022

The sooner a human-centred perspective is applied to the development of either a drug or device product, the more likely the product will be adopted and used because it’s been designed around what the end consumer wants and needs. This will ensure that you are developing a product these audiences will use.

Life Science 105

Life Science Production Development Drugs 105

Pharma Business Blog

NOVEMBER 1, 2020

Dear pharma & life sciences colleagues, As a tax/regulatory specialist within a pharmaceutical & life sciences company, you face complex sector-specific challenges each and every day. That is why we would like to introduce the PwC Pharma & Life Science Radar to you. November 11:00 CET.

Life Science 52

Life Science Development Regulation Trials 52

Pharmaceutical Technology

NOVEMBER 3, 2022

Emalex Biosciences has raised Series D funds worth $250m led by Bain Capital Life Sciences to progress the development of an investigational new drug for Tourette syndrome. Headache, somnolence, fatigue, insomnia and restlessness were found to be the most common adverse events linked to ecopipam in the trial.

Development 130

Development Drugs Clinical Trials Clinical Trials 130

XTalks

JULY 6, 2022

In this episode, Ayesha discussed a new collaboration between leading medical technology company Becton Dickinson (BD) and CerTest Biotec who will work together to develop a molecular diagnostic test for the detection of the monkeypox virus. Hear about the vaccine trials and parents’ attitudes towards vaccinating younger children.

Life Science 52

Life Science Vaccination Vaccine Development 52

pharmaphorum

JULY 22, 2022

A just-published report on the UK’s life sciences sector “ought to ring alarm bells across government,” according to the Association of the British Pharmaceutical Industry (SBPI). The Life Sciences Competitiveness Indicators report shows that spending on life sciences R&D was £2.7

Life Science 52

Life Science Clinical Trials Clinical Trials Medicine 52

Pharmaceutical Technology

JUNE 9, 2023

Co-led by Venrock Healthcare Capital Partners (Venrock) and Enavate Sciences, the financing round has seen participation from new investors Wellington Management and Bain Capital Life Sciences. It is also preparing for a swift transition to Phase III development.

Clinical Development 147

Clinical Development Development Life Science Clinical Trials 147